136 related articles for article (PubMed ID: 823676)
1. [Myositis ossificans progressiva treated with diphosphonate].
Glenting P
Ugeskr Laeger; 1976 Sep; 138(39):2362-6. PubMed ID: 823676
[No Abstract] [Full Text] [Related]
2. Myositis ossificans progressiva. Clinical features of eight patients and their response to treatment.
Smith R; Russell RG; Woods CG
J Bone Joint Surg Br; 1976 Feb; 58(1):48-57. PubMed ID: 818090
[TBL] [Abstract][Full Text] [Related]
3. Chronic intoxication by ethane-1-hydroxy-1,1-diphosphonate (EHDP) in a child with myositis ossificans progressiva.
Pazzaglia UE; Beluffi G; Ravelli A; Zatti G; Martini A
Pediatr Radiol; 1993; 23(6):459-62. PubMed ID: 8255652
[TBL] [Abstract][Full Text] [Related]
4. Fibrodysplasia ossificans progressiva. An 11-year-old boy treated with a diphosphonate.
Bruni L; Giammaria P; Tozzi MC; Camparcola D; Scopinaro F; Imperato C
Acta Paediatr Scand; 1990 Oct; 79(10):994-8. PubMed ID: 2124774
[TBL] [Abstract][Full Text] [Related]
5. Editorial: Diphosphonate treatment in bone disease.
Fleisch H; Bonjour JP
N Engl J Med; 1973 Dec; 289(26):1419-20. PubMed ID: 4201877
[No Abstract] [Full Text] [Related]
6. Fibrodysplasia (myositis) ossificans progressiva treated with disodium etidronate.
Hentzer B; Jacobsen HH; Asboe-Hansen G
Clin Radiol; 1978 Jan; 29(1):69-75. PubMed ID: 414874
[TBL] [Abstract][Full Text] [Related]
7. Fibrodysplasia ossificans progressiva (myositis ossificans progressiva) treatment with disodium etidronate.
Hall JG; Schaller JG; Worsham NG; Horning MR; Staheli LT
J Pediatr; 1979 Apr; 94(4):679-80. PubMed ID: 107305
[No Abstract] [Full Text] [Related]
8. Fibrodysplasia ossificans progressiva: current concepts and the role of CT in acute changes.
Lindhout D; Golding RP; Taets van Amerongen AH
Pediatr Radiol; 1985; 15(3):211-3. PubMed ID: 3921936
[TBL] [Abstract][Full Text] [Related]
9. Fibrodysplasia ossificans progressiva (FOP) treated with diphosphonate.
Elliott DE
Birth Defects Orig Artic Ser; 1974; 10(12):515-20. PubMed ID: 4218791
[No Abstract] [Full Text] [Related]
10. Fibrodysplasia ossificans progressiva.
Tonholo-Silva ER; Adachi EA; Tafner MS; Yoshinaga L
Arq Neuropsiquiatr; 1994 Mar; 52(1):100-2. PubMed ID: 8002796
[TBL] [Abstract][Full Text] [Related]
11. Myositis ossificans progressiva: a 10-year follow-up on a patient treated with etidronate disodium.
Bar Oz B; Boneh A
Acta Paediatr; 1994 Dec; 83(12):1332-4. PubMed ID: 7734885
[TBL] [Abstract][Full Text] [Related]
12. Fibrodysplasia ossificans progressiva. A survey of forty-two cases.
Rogers JG; Geho WB
J Bone Joint Surg Am; 1979 Sep; 61(6A):909-14. PubMed ID: 113413
[TBL] [Abstract][Full Text] [Related]
13. Fibrodysplasia ossificans progressiva.
Chopra K; Saha MM; Saluja S
Indian Pediatr; 1987 Aug; 24(8):677-80. PubMed ID: 3127343
[No Abstract] [Full Text] [Related]
14. Use and complications of high-dose disodium etidronate therapy in fibrodysplasia ossificans progressiva.
Rogers JG; Dorst JP; Geho WB
J Pediatr; 1977 Dec; 91(6):1011-4. PubMed ID: 411907
[TBL] [Abstract][Full Text] [Related]
15. Familial fibrodysplasia ossificans progressiva: trial with etidronate disodium.
Dua T; Kabra M; Kalra V
Indian Pediatr; 2001 Nov; 38(11):1305-9. PubMed ID: 11721075
[No Abstract] [Full Text] [Related]
16. Progressive ossifying myositis in a cat.
Waldron D; Pettigrew V; Turk M; Turk J; Gibson R
J Am Vet Med Assoc; 1985 Jul; 187(1):64-5. PubMed ID: 3926735
[TBL] [Abstract][Full Text] [Related]
17. Myositis ossificans progressiva: a review of current problems.
Smith R
Semin Arthritis Rheum; 1975 May; 4(4):369-80. PubMed ID: 806117
[No Abstract] [Full Text] [Related]
18. A 3 year old girl with fibrodysplasia ossificans progressiva.
Ali NS; Qureshi R
J Pak Med Assoc; 1999 Sep; 49(9):223-5. PubMed ID: 10646326
[No Abstract] [Full Text] [Related]
19. Treatment of myositis ossificans progressiva with a diphosphonate.
Russell RG; Smith R; Bishop MC; Price DA
Lancet; 1972 Jan; 1(7740):10-1. PubMed ID: 4108814
[No Abstract] [Full Text] [Related]
20. [Neurogenic myositis ossificans - report of two cases with a discussion on the therapeutic use of ethanehydroxydiphosphonate (EHDP)].
Ye QB; Wang GS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1981 Jun; 3 Suppl 1():5-8. PubMed ID: 6459878
[No Abstract] [Full Text] [Related]
[Next] [New Search]
